TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Reven Stock

Reven Stock

reven.comHealthcare / BioTech & PharmaFounded: 1999Funding to Date: $106.23MM

Reven Pharmaceuticals was established in 1999 and is based in Broomfield, CO. Reven constantly pushes the boundaries of science and technology to pursue scientific innovation to improve overall health and well-being. Conducting research identifying potential target therapeutic areas, social accountability by serving patients and the families who cherish them, and creating a pipeline that investigates neglected diseases.

Buy or sell Reven stockLearn more about Reven IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Reven, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Reven’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Reven.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Brian Denomme
Chief Operating Officer & Board Member
Michael Volk
Chief Financial Officer & Board Member
James Ervin
Chief Technology Officer
Peter Lange
Founder, Board Member & Chief Executive Officer
Henk Van Wyk
Chief Scientist

Board Members

Brian Denomme
Chief Operating Officer & Board Member
Michael Volk
Chief Financial Officer & Board Member
Peter Lange
Founder, Board Member & Chief Executive Officer

Frequently Asked Questions About Reven’s Stock

plusminus
Can you buy Reven’s stock?
Reven is not publicly traded on NYSE or NASDAQ in the U.S. To buy Reven’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Reven’s stock?
Yes, you can sell stock of a private company like Reven. Forge can help you sell your Reven stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Reven’s stock price?
Reven is a privately held company and therefore does not have a public stock price. However, you may access Reven’s private market stock price with Forge Data.
plusminus
What is Reven’s stock ticker symbol?
Reven does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Reven in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

04/09/2018
Critical Limb Ischemia (CLI) – Major Players Involved in Therapy Development
New Delhi, India -- (SBWIRE) -- 04/09/2018 -- Critical Limb Ischemia (CLI) is a severe form of peripheral artery disease (PAD). It occurs with severe obstructions in the arteries which leads to reduced blood flow to the extremities.
11/03/2016
The top 15 healthcare deals of 2016
There has been $13.1 billion invested across 1,287 deals so far this year

Trending Companies

Frequently Asked Questions

Updated on: Apr 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.